NOACs Bleeding Prediction (NBP): points-based risk-scoring system* for major bleeding
| Variable | Level | Points |
| Sex | Female | 0 |
| Male | 7 | |
| Anaemia (male: Hb <13 g/dL, female: HB <12 g/dL) | No | 0 |
| Yes | 6 | |
| Thrombocytopaenia | Normal/mild | 0 |
| Moderate/severe (<99×103/µL) | 9 | |
| Concurrent antiplatelet therapy | No | 0 |
| Yes | 7 | |
| Hypertension | No | 0 |
| Yes | 8 | |
| Prior major bleeding | No | 0 |
| Yes | 5 | |
| Known fall risk (dementia, Parkinson’s disease, gait problem, prior fall, hip fracture) | No | 0 |
| Yes | 4 | |
| Serum cholesterol (mg/dL) | ≥240 | 0 |
| 200–239 | 1 | |
| 160–199 | 2 | |
| <160 | 5 | |
| eGFR (mL/min) | ≥90 | 0 |
| 60–89 | 4 | |
| 30–59 | 6 | |
| ≤29 | 8 |
*The points from each variable must be added up to obtain the total risk score.
eGFR, estimated glomerular filtration rate; NOACs, new oral anticoagulants .